Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder

NCT04179734 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hypoactive Sexual Desire Disorder

Interventions

DRUG: Bremelanotide
DRUG: Placebo

Sponsor

Imperial College Healthcare NHS Trust

Collaborators

[object Object]